Cargando…
A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease
BACKGROUND: Chronic kidney disease (CKD) is associated with an increased risk of hepatitis B infection and impaired seroconversion to hepatitis B vaccine (HBV). Studies examining augmented vaccine schedules to enhance seroconversion have so far been inconclusive. Furthermore, the defects responsible...
Autores principales: | da Silva, Elizabeth N., Baker, Alan, Alshekaili, Jalila, Karpe, Krishna, Cook, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179249/ https://www.ncbi.nlm.nih.gov/pubmed/30303980 http://dx.doi.org/10.1371/journal.pone.0204477 |
Ejemplares similares
-
A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
por: Al Sukaiti, Nashat, et al.
Publicado: (2021) -
Serological and vaccine evaluation for hepatitis B among Community Health Workers
por: Amaral, Tauana de Souza, et al.
Publicado: (2023) -
Serological and molecular characterization of hepatitis B virus infection in chronic kidney disease patients from Rio de Janeiro, Brazil
por: Villar, Livia Melo, et al.
Publicado: (2022) -
Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center
por: Al Farsi, Tariq, et al.
Publicado: (2022) -
Proteomics: Concepts and applications in human medicine
por: Al-Amrani, Safa, et al.
Publicado: (2021)